Patents by Inventor David Sabate Elias

David Sabate Elias has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

Pyrazoline-derived compound and its use in a weekly dosage regime against inflammation and pain derived from degenerative joint disease in mammals

Patent number: 11154536

Abstract: The present invention refers to the use of the compounds E-6087 in a weekly dosage regime for the treatment of pain and inflammation associated to a degenerative joint disease such as osteoarthritis or a condition associated to any such disease such as lameness. The present invention is directed to the treatment of mammals, preferably of dogs.

Type: Grant

Filed: October 13, 2015

Date of Patent: October 26, 2021

Assignee: ECUPHAR N.V.

Inventors: Josep Homedes-Beguer, David Sabate-Elias
PYRAZOLINE-DERIVED COMPOUND AND ITS USE IN A WEEKLY DOSAGE REGIME AGAINST INFLAMMATION AND PAIN DERIVED FROM DEGENERATIVE JOINT DISEASE IN MAMMALS

Publication number: 20170231961

Abstract: The present invention refers to the use of the compounds E-6087 in a weekly dosage regime for the treatment of pain and inflammation associated to a degenerative joint disease such as osteoarthritis or a condition associated to any such disease such as lameness. The present invention is directed to the treatment of mammals, preferably of dogs.

Type: Application

Filed: October 13, 2015

Publication date: August 17, 2017

Applicant: ECUPHAR n.v.

Inventors: Josep Homedes-Beguer, David Sabate-Elias
Domperidone at a low daily dose for use in the treatment or prevention of a disease associated with an alteration of the immune response

Patent number: 8802691

Abstract: The invention relates to the use of domperidone or a pharmaceutically acceptable salt thereof at low doses to prevent and/or treat a disease associated with an alteration of the immune response such as Leishmaniosis.

Type: Grant

Filed: March 30, 2010

Date of Patent: August 12, 2014

Assignee: Laboratorios del Dr. Esteve, S.A.

Inventors: David Sabate Elias, Josep M. Homedes Beguer, Pablo Gomez Ochoa
DOMPERIDONE AT A LOW DAILY DOSE FOR USE IN THE TREATMENT OR PREVENTION OF A DISEASE ASSOCIATED WITH AN ALTERATION OF THE IMMUNE RESPONSE

Publication number: 20120065167

Abstract: The invention relates to the use of domperidone or a pharmaceutically acceptable salt thereof at low doses to prevent and/or treat a disease associated with an alteration of the immune response such as Leishmaniosis.

Type: Application

Filed: March 30, 2010

Publication date: March 15, 2012

Applicant: LABORATORIOS DEL DR. ESTEVE S.A.

Inventors: David Sabate Elias, Josep M. Homedes Beguer, Pablo Gomez Ochoa

Pyrazoline-derived compound and its use in a weekly dosage regime against inflammation and pain derived from degenerative joint disease in mammals

PYRAZOLINE-DERIVED COMPOUND AND ITS USE IN A WEEKLY DOSAGE REGIME AGAINST INFLAMMATION AND PAIN DERIVED FROM DEGENERATIVE JOINT DISEASE IN MAMMALS

Domperidone at a low daily dose for use in the treatment or prevention of a disease associated with an alteration of the immune response

DOMPERIDONE AT A LOW DAILY DOSE FOR USE IN THE TREATMENT OR PREVENTION OF A DISEASE ASSOCIATED WITH AN ALTERATION OF THE IMMUNE RESPONSE